Trastuzumab Completed Phase 2 Trials for Urinary Tract Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02006667A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer